We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.37B
1-Year Est. Return
71.68%
This Fund
S&P 500
This Quarter
Est. Return
-0.12%
1 Year Est. Return
+71.68%
3 Year Est. Return
+198.05%
5 Year Est. Return
+324.32%
10 Year Est. Return
+2,686.25%
AUM
$3.91B
AUM Growth
+$545M
(+16%)
Cap. Flow
+$16.3M
Cap. Flow
% of AUM
0.42%
Top 10 Holdings %
Top 10 Hldgs %
40.38%
Holding
2,228
New
603
Increased
482
Reduced
356
Closed
557
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$84.4M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$81.5M |
| 3 |
Valaris
VAL
|
+$24.1M |
| 4 |
CAI
CAI International, Inc.
CAI
|
+$12.6M |
| 5 |
STMP
Stamps.com, Inc.
STMP
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$22.9M |
| 2 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$19.4M |
| 3 |
PFPT
Proofpoint, Inc.
PFPT
|
+$19M |
| 4 |
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
|
+$16.1M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$15.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 62.32% |
| 2 | Financials | 9.78% |
| 3 | Technology | 7.1% |
| 4 | Consumer Discretionary | 5.21% |
| 5 | Industrials | 4.36% |
Similar funds
CA
MCI
WC
OCAI
AIP
FBCM
FCM
KPF
Prelude Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Prelude Capital Management held 2,228 positions worth $3.91B, up 16% from $3.36B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Prelude Capital Management's Q3 2021 filing shows 603 new, 482 increased, 356 reduced and 557 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 208,151 shares worth $82.1M. The largest sale was Alexion Pharmaceuticals, an estimated $22.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 62% of assets, up from 52% a quarter earlier, followed by Financials and Technology.
- Prelude Capital Management's largest Q3 2021 buy was Vanguard S&P 500 ETF: 208,151 shares worth $82.1M.
- Prelude Capital Management added most to Valaris in Q3 2021, an estimated $24.1M increase.
- Prelude Capital Management's biggest Q3 2021 reduction was Frontier Communications, cutting an estimated $8.65M.
- Prelude Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $22.9M.
- Prelude Capital Management's ten largest holdings make up 40% of its $3.91B portfolio in Q3 2021.
- Prelude Capital Management opened 603 new positions and closed 557 in Q3 2021.
- Prelude Capital Management's portfolio value rose 16% quarter-over-quarter to $3.91B.
Based on Prelude Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.